BEUDAMED
    10 results · 20ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.
    Filters Regulation: Us FDA ×

    RAYNER SINGLE USE SOFT TIPPED DISPOSABLE INJECTOR, MODEL R-INJ-04

    FDA 510(k)
    FDA Class 1 ·Ophthalmic

    Mul-T-Pad

    FDA UDI
    STRYKER CORPORATION·07613327261325·

    Mul-T-Pad

    FDA UDI
    C2DX, INC.·10850007350090·Temperature Therapy Pad

    CLEARMEDICAL/NOVAMEDIX AVI FOOT COVER, PAIR, REGULAR & LARGE SIZE

    FDA 510(k)
    FDA Class 2 ·Cardiovascular

    BARDEX I.C.PLUS FOLEY CATHETER WITH SILVER SALTS IN HYDROGEL COATING, MODEL 3CC BALLOON: 17008,170010,5CC BALLOON

    FDA 510(k)
    FDA Class 2 ·Gastroenterology, Urology

    AED PLUS

    FDA Adverse Event
    Malfunction ·ZOLL MEDICAL CORPORATION·Product code MKJ·March 18, 2013

    V-LOC 90 ABS CLOS DEVICE 3-0 CL 18 P-12

    FDA Adverse Event
    Injury ·UNITED STATES SURGICAL·Product code GAM·April 8, 2011

    HCPII ACETABULAR COMPONENT LONGEVITY CROSSLINKED POLYETHYLENE LINER STANDARD

    FDA Adverse Event
    Injury ·ZIMMER, INC.·Product code KWB·June 18, 2008

    Stryker MA204 Bed Model (FL25E) Beds are intended for medical purposes in both general patient care as well as critical care environments. Each uses built-in electric motors and controls which can be operated by the patient, or caregiver, to adjust the height and/or surface contour of the bed.The devices listed above also include movable and latchable side rails which can be lowered or raised to help prevent patient fall and subsequent injury. The Beds include an optional Scale (Models: FL20E, FL25E, FL28C, FL28EX) as well as an optional Bed Exit (1 Zone) or Chaperone

    FDA Enforcement
    Class II ·Terminated·Stryker Medical Division of Stryker Corporation·July 4, 2012

    CADD¿- Solis Ambulatory Infusion Pump, Model 2111 & 2112, Version 1.0, Version 2.0 and Version 3.0 & Model 2120, Version 1.0. Provide measured drug therapy to patients in hospital or outpatient settings.

    FDA Enforcement
    Class II ·Terminated·Smiths Medical ASD, Inc.·June 24, 2015